Vaccines, blood, antisera, toxins and cultures in   Gambia

Exports In 2022, Gambia exported $57k in Vaccines, blood, antisera, toxins and cultures, making it the 140th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 64th most exported product in Gambia. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Gambia are: Belgium ($50.9k), Sweden ($5.93k), Germany ($138), and South Africa ($11).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Gambia between 2021 and 2022 were Belgium ($50.9k), Sweden ($5.93k), and Germany ($138).

Imports In 2022, Gambia imported $6.92M in Vaccines, blood, antisera, toxins and cultures, becoming the 167th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 41st most imported product in Gambia. Gambia imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($4.54M), United States ($1.08M), India ($780k), South Korea ($321k), and China ($55.6k).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Gambia between 2021 and 2022 were United States ($1.08M), Belgium ($398k), and Japan ($29.5k).